Brainstorm Cell Therapeutics (BCLI) Q3 2022 Earnings Report

BCLI Q3 2022 EPS Results

Actual EPS: -$2.85
Consensus EPS: -$2.70
Beat/Miss: Missed by -$0.15
One Year Ago EPS: -$2.25

BCLI Q3 2022 Revenue Results

Actual Revenue: $0
Expected Revenue: $0
Beat/Miss: Met expectations
YoY Revenue Growth: ―

Earnings Announcement Details

Quarter: Q3 2022
Date: 11/14/2022
Time: Before Open
Conference Call: Monday, November 14, 2022

BCLI Upcoming Earnings

Brainstorm Cell Therapeutics's next earnings date is estimated for November 16, 2026, based on past reporting schedules.

Q3 2022 Earnings Call Audio

BCLI Q3 2022 Earnings Call

0:00 / 0:00

Q3 2022 Earnings Slide Deck

No slide deck is available for this earnings event.

Q3 2022 Earnings Call Summary

No earnings call summary is available for this earnings event.

BCLI Earnings History

BCLI earnings history
Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Press Release
Nov 16, 2026	2026 (Q3)	-0.18-	-0.19	―	―
Aug 14, 2026	2026 (Q2)	―-0.35	-0.34	-2.94% (-0.01)
May 15, 2026	2026 (Q1)	―-0.19	-0.45	57.78% (+0.26)
Mar 31, 2026	2025 (Q4)	-0.28-0.19	-0.45	57.78% (+0.26)
Nov 14, 2025	2025 (Q3)	-0.37-0.19	-0.51	62.75% (+0.32)
Aug 14, 2025	2025 (Q2)	-0.37-0.34	0.6	-156.67% (-0.94)
May 16, 2025	2025 (Q1)	―-0.45	-0.75	40.00% (+0.30)
Mar 31, 2025	2024 (Q4)	-0.97-0.45	-0.75	40.00% (+0.30)
Nov 14, 2024	2024 (Q3)	-0.57-0.51	-0.45	-13.33% (-0.06)
Aug 14, 2024	2024 (Q2)	-0.530.60	-1.95	130.77% (+2.55)
May 14, 2024	2024 (Q1)	―-	-0.14	―
Apr 01, 2024	2023 (Q4)	-1.05-0.75	-2.1	64.29% (+1.35)
Nov 14, 2023	2023 (Q3)	-2.25-0.45	-2.85	84.21% (+2.40)
Aug 14, 2023	2023 (Q2)	-2.17-1.95	-2.85	31.58% (+0.90)
May 15, 2023	2023 (Q1)	-2.48-2.10	-2.25	6.67% (+0.15)
Mar 30, 2023	2022 (Q4)	-2.17-3.08	-1.13	-173.33% (-1.95)
Nov 14, 2022	2022 (Q3)	-2.70-2.85	-2.25	-26.67% (-0.60)
Aug 15, 2022	2022 (Q2)	-2.20-2.85	-2.55	-11.76% (-0.30)
May 16, 2022	2022 (Q1)	-1.95-2.25	-2.85	21.05% (+0.60)
Mar 28, 2022	2021 (Q4)	-2.95-1.13	-5.4	79.17% (+4.28)
Nov 15, 2021	2021 (Q3)	-3.60-2.25	-2.1	-7.14% (-0.15)
Aug 05, 2021	2021 (Q2)	-3.60-2.55	-3.75	32.00% (+1.20)
Apr 26, 2021	2021 (Q1)	―-2.85	-4.8	40.63% (+1.95)
Feb 04, 2021	2020 (Q4)	―-5.40	-5.1	-5.88% (-0.30)
Oct 15, 2020	2020 (Q3)	―-2.10	-3.75	44.00% (+1.65)
Aug 05, 2020	2020 (Q2)	―-0.25	-0.23	-8.70% (-0.02)
May 07, 2020	2020 (Q1)	―-0.32	-0.24	-33.33% (-0.08)
Feb 18, 2020	2019 (Q4)	―-0.34	-0.27	-25.93% (-0.07)
Nov 14, 2019	2019 (Q3)	―-0.25	-0.15	-66.67% (-0.10)
Aug 13, 2019	2019 (Q2)	―-0.23	-0.16	-43.75% (-0.07)
May 10, 2019	2019 (Q1)	―-0.24	-0.12	-100.00% (-0.12)
Mar 29, 2019	2018 (Q4)	―-0.27	0.01	-2800.00% (-0.28)
Oct 29, 2018	2018 (Q3)	―-0.15	-0.13	-15.38% (-0.02)
Jul 23, 2018	2018 (Q2)	―-0.16	-0.06	-166.67% (-0.10)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed

Brainstorm Cell Therapeutics earnings date